SAB Biotherapeutics Inc. (SABSW)
undefined
undefined%
At close: undefined
0.05
0.00%
After-hours Dec 13, 2024, 02:16 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 2.24M 23.90M 60.88M 55.24M 3.44M
Cost of Revenue 3.75M 3.29M 1.65M - -
Gross Profit -1.51M 20.61M 59.22M 55.24M 3.44M
Operating Income -38.08M -28.92M -13.39M 20.56M -8.67M
Interest Income 584.97K 71.07K 23.11K 26.13K 113.13K
Pretax Income -42.19M -18.72M -17.14M 20.12M -8.99M
Net Income -42.19M -18.74M -17.44M 20.12M -9.42M
Selling & General & Admin 20.05M 16.38M 17.09M 6.77M 4.10M
Research & Development 16.52M 36.44M 57.18M 27.91M 8.02M
Other Expenses - -23.90M -60.88M 4.00K 2.59K
Operating Expenses 40.31M 28.92M 13.39M 34.68M 12.12M
Interest Expense 315.28K 301.58K 294.46K 469.15K 428.48K
Selling & Marketing Expenses -3.75M - - - -
Cost & Expenses 40.31M 28.92M 13.39M 34.68M 12.12M
Income Tax - 25.63K 299.95K 473.15K 431.07K
Shares Outstanding (Basic) 5.52M 4.35M 2.73M 2.54M 43.47M
Shares Outstanding (Diluted) 5.52M 4.35M 2.73M 2.70M 43.47M
EPS (Basic) -7.64 -4.31 -6.38 7.92 -0.22
EPS (Diluted) -7.64 -4.31 -6.38 7.45 -0.22
EBITDA -38.08M -15.12M -15.20M 21.14M -8.23M
Depreciation & Amortization 3.75M 3.29M 1.65M 548.18K 323.41K